Price$0.47-0.03 (-6.00%)
01:30 PM05:30 PM
News · 26 weeks39+17%
2025-11-022026-04-26
Mix1990d
- Other9(47%)
- SEC Filings8(42%)
- Earnings2(11%)
Latest news
25 items- SECBIO-key International Inc. filed SEC Form 8-K: Material Modification to Rights of Security Holders, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Other Events, Financial Statements and Exhibits8-K - BIO KEY INTERNATIONAL INC (0001019034) (Filer)
- PRFollowing Stockholder Approval, BIO-key Announces 1-for-10 Reverse Stock SplitHOLMDEL, N.J., April 28, 2026 (GLOBE NEWSWIRE) -- BIO-key® International, Inc. (NASDAQ:BKYI), a global leader in Identity and Access Management (IAM) and biometric authentication technologies, today announced that it has approved a 1-for-10 reverse stock split that will become effective with the commencement of trading on April 30, 2026. BIO-key stockholders approved a proposal last week to allow the Board to proceed with a reverse split to assist the Company in its effort to regain compliance with the minimum bid price requirement. BIO-key had approximately 10.9 million shares of common stock issued and outstanding as of April 28, 2026. After giving effect to the 1-for-10 reverse stock
- SECBIO-key International Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders8-K - BIO KEY INTERNATIONAL INC (0001019034) (Filer)
- SECBIO-key International Inc. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Regulation FD Disclosure, Financial Statements and Exhibits8-K - BIO KEY INTERNATIONAL INC (0001019034) (Filer)
- PRBIO-key Receives Notice of Non-Compliance from Nasdaq Related to Delay of its Form 10-K FilingHOLMDEL, N.J., April 22, 2026 (GLOBE NEWSWIRE) -- BIO-key International, Inc. (NASDAQ:BKYI), a global leader in Identity and Access Management (IAM) and biometric authentication technologies, announced today that it has received a notification letter from The Nasdaq Stock Market, LLC informing the Company that it was not in compliance with Nasdaq Listing Rule 5250(c)(1), which requires listed companies to timely file all required periodic financial reports with the Securities and Exchange Commission, due to the Company's failure to timely file its Annual Report on Form 10-K for the year ended December 31, 2025. The Notification Letter has no immediate effect on the listing or trading of th
- SECBIO-key International Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits8-K - BIO KEY INTERNATIONAL INC (0001019034) (Filer)
- PRBIO-key Expects 50% Increase in First Half Revenues, Driving Profitability in the PeriodHOLMDEL, N.J., April 16, 2026 (GLOBE NEWSWIRE) -- BIO-key® International, Inc. (NASDAQ:BKYI), a global leader in Identity and Access Management (IAM) and biometric authentication technologies, previewed today its business outlook for the first half of 2026 (1H'26) ending June 30, 2026, supported by building software license momentum and strength in hardware revenues. Expected 1H'26 Results: 1H'26 revenues expected to grow 50% to approximately $5M vs. $3.3M in 1H'25Positive net income expected in 1H'26 vs. $1.9M net loss in 1H'25Cash position at the close of 1H'26 is expected to remain in line with $2.7M at year-end 2025 Q1'26 & Q2'26 Expected Revenues: Q1'26 revenues expected to grow 3
- SECSEC Form NT 10-K filed by BIO-key International Inc.NT 10-K - BIO KEY INTERNATIONAL INC (0001019034) (Filer)
- SECBIO-key International Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits8-K - BIO KEY INTERNATIONAL INC (0001019034) (Filer)
- PRBIO-key Reports 2025 Results and Substantially Improved Cash Position, Supporting Expected Strong Growth in 2026; Investor Call Today at 10am ETHOLMDEL, N.J., March 31, 2026 (GLOBE NEWSWIRE) -- BIO-key® International, Inc. (NASDAQ:BKYI), a global leader in Identity and Access Management (IAM) and biometric authentication technologies, announced its fourth quarter (Q4'25) and year ended December 31, 2025 (2025) results. BIO-key will host an investor call today at 10:00am ET (details below). Highlights: • 2025 Revenue: $6.1M • 2026 Outlook: Solid revenue growth + improved bottom line • Preliminary Q1'26 Revenue: $2.2M, up 37% vs. Q1'25 and 80% vs. Q4'25 • 2025 Cash Position: $2.7M, up $2.3M vs. $0.4M vs. 2024 BIO-key CEO, Mike DePasquale commented, "We had a broad base of achievements in 2025, the revenue and bottom-line benefits
- PRIdentity and Biometric Authentication Cybersecurity Provider BIO-key to Host Year-End Investor Call Tuesday, March 31st at 10am ETHOLMDEL, N.J., March 25, 2026 (GLOBE NEWSWIRE) -- BIO-key International, Inc. (NASDAQ:BKYI), a global leader in Identity and Access Management (IAM) and biometric authentication technologies, will host its 2025 year-end investor call on Tuesday, March 31st at 10 a.m. ET with results issued prior the market opening. Mike DePasquale, Chairman & CEO and Cecilia Welch, CFO will lead the conference call and Q&A session. Call Details Date / Time:Tuesday, March 31st at 10 a.m. ETCall Dial In #:1-877-418-5460 U.S. or 1-412-717-9594 Int'lLive Webcast / Replay:Webcast & Replay Link – Available for 3 months.Audio Replay:1-855-669-9658 U.S. or 1-412-317-0088 Int'l; code 4802902 About BIO-key Internati
- SECSEC Form DEF 14A filed by BIO-key International Inc.DEF 14A - BIO KEY INTERNATIONAL INC (0001019034) (Filer)
- PRBIO-key Partners with TD SYNNEX Public Sector (DLT) to Deliver Identity-Bound Biometric and IAM Solutions to the U.S. Public SectorHOLMDEL, N.J., March 12, 2026 (GLOBE NEWSWIRE) -- BIO-key® International, Inc. (NASDAQ:BKYI), an innovative provider of workforce and customer identity and access management (IAM) solutions enabling phoneless, tokenless, passwordless, and phishing-resistant authentication, today announced a strategic partnership with TD SYNNEX Public Sector (DLT Solutions), a leading technology partner to the U.S. public sector, to bring BIO-key's comprehensive suite of security solutions to federal, state, and local government agencies. DLT is a unit of TD SYNNEX (NYSE:SNX), a leading global end-to-end distributor of technology products, services and solutions. As government entities face increasing mand
- SECSEC Form PRE 14A filed by BIO-key International Inc.PRE 14A - BIO KEY INTERNATIONAL INC (0001019034) (Filer)
- PRBIO-key Surpasses $2M of Military/Defense Sales over Last 12 months with Follow-on Order From Foreign Defense Ministry; Geopolitical Tensions Raise Stakes for Securing Intelligence Against Cyber ThreatsHOLMDEL, N.J., March 05, 2026 (GLOBE NEWSWIRE) -- BIO-key® International, Inc. (NASDAQ:BKYI), a provider of biometric-centric Identity and Access Management (IAM) solutions, today announced that the cyber-defense unit of a foreign defense ministry placed a $280,000 in new order to expand its deployment of BIO-key's biometric user authentication to additional personnel. The order brings total business booked from this customer in the past 12 months to $1.14M with additional orders expected. Across the broader military and defense sector BIO-key has secured over $2M in total orders over the last 12 months, representing a substantial increase over the year-ago period. Rising geopolitical ten
- SECBIO-key International Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits8-K - BIO KEY INTERNATIONAL INC (0001019034) (Filer)
- PRRetail Bank Executes Expanded $1.04M License Renewal for BIO-key Biometric Identity Solution Serving 30M ClientsHOLMDEL, N.J., March 03, 2026 (GLOBE NEWSWIRE) -- BIO-key® International, Inc. (NASDAQ:BKYI), a global leader in biometric-centric Identity and Access Management (IAM) solutions, today announced it has secured a $1.04M license renewal and expansion order for its biometric identification solution from a foreign retail bank, a customer since 2015. Reflecting the customer's ongoing expansion of the solution's deployment, the value of the one-year renewal increased 30% over the prior year. BIO-key also disclosed that based on its year-end cash position of $2.7M, anticipated license renewal activity including today's announcement, and anticipated receivables collections, it believes it has suf
- PRBIO-key and RunLevel Strengthen Identity Security Across Mozambique's National Payments Infrastructure for Sociedade Interbancária de Moçambique (SIMO)MAPUTO, Mozambique and HOLMDEL, N.J., Feb. 24, 2026 (GLOBE NEWSWIRE) -- BIO-key® International, Inc. (NASDAQ:BKYI), a global leader in biometric-centric Identity and Access Management (IAM) solutions, today announced a new strategic, multi-year agreement with Sociedade Interbancária de Moçambique (SIMO), the operator of Mozambique's national electronic payments network. Working in partnership with RunLevel, a specialized regional integrator with identity and cybersecurity experience across Africa, BIO-key will support the modernization of identity and access security across SIMO's financial ecosystem. The agreement builds on BIO-key's and RunLevel's first joint IAM deployment in Mozambique
- PRBIO-key EMEA Subsidiary Partners with Citadel Global to Expand India Presence and Accelerate Adoption of Biometric Identity Solutions in Support of EU–India Free Trade AgreementMADRID and MUMBAI, India, Jan. 29, 2026 (GLOBE NEWSWIRE) -- BIO-key International, Inc. (NASDAQ:BKYI), a global leader in Identity and Access Management (IAM) and biometric authentication solutions, today announced the planned launch of a Mumbai office, its first in India. This new presence will be staffed by a local team and supported by a newly formed partnership with Citadel Global, a trusted value-added distributor (VAD) with deep expertise in national and enterprise-scale cybersecurity and identity solutions. The India initiative, led by BIO-key's Europe, Middle East and Africa (EMEA) subsidiary , is in support of the European Union and India free-trade agreement signed earlier this
- PRBIO-key and Visualforma Awarded Contract to Secure Digital Identities for Large Municipality in PortugalHOLMDEL, N.J. and FARO, Portugal, Jan. 28, 2026 (GLOBE NEWSWIRE) -- BIO-key International, Inc. (NASDAQ:BKYI), a leading provider of Identity and Access Management (IAM) and biometric authentication solutions, today announced a strategic partnership with Visualforma (https://visualforma.pt/), a Portuguese technology integrator specializing in digital transformation and secure IT solutions. This partnership supports the launch of a new line of business focused on Portuguese municipal councils, enabling the deployment of advanced digital identity and access management to strengthen cybersecurity and improve access to public digital services. Visualforma will lead the nationwide rollout of B
- NEWSDealFlow Discovery Conference Announces Initial Lineup of Presenting Companies Ahead of Next Week's EventATLANTIC CITY, NJ / ACCESS Newswire / January 23, 2026 / DealFlow Events today announced the growing list of companies scheduled to present and participate in one-on-one meetings with investors and analysts at the DealFlow Discovery Conference, taking place January 28-29, 2026, at the Borgata Hotel Casino & Spa in Atlantic City.More than 100 public and private companies are expected to participate in the conference, which brings together investors, analysts, growth company executives, and capital markets professionals for two days of company presentations, structured networking, and pre-scheduled 1:1 meetings.Below is the current list of companies confirmed to present and take meetings. Publ
- NEWSBiometric Identification and Cybersecurity Software Solutions Provider BIO-key Presents at DealFlow Discovery Investor Conference at 11:30am ET, Jan. 28 in Atlantic City, NJATLANTIC CITY & HOLMDEL, NJ / ACCESS Newswire / January 13, 2026 / BIO-key® International, Inc. (NASDAQ:BKYI), a leading provider of biometric enabled Identity and Access Management SaaS solutions for phoneless, tokenless, passwordless, and phish-resistant authentication, will participate at the DealFlow Discovery Conference Wednesday and Thursday, January 28th and 29th at the Borgata hotel in Atlantic City, New Jersey. Institutional investors, family offices and high-net-worth investors are invited to attend at no cost.BIO-key CEO Mike DePasquale will present on Wednesday at 11:30 am ET in Room 1 and will be available for 1-on-1 meetings throughout the event. BIO-key's presentation details
- INSIDERChief Technology Officer Lacous Mira K was granted 2,500 shares, increasing direct ownership by 7% to 38,258 units (SEC Form 4)4 - BIO KEY INTERNATIONAL INC (0001019034) (Issuer)
- INSIDERChief Legal Officer Sullivan James David was granted 2,500 shares, increasing direct ownership by 3% to 97,351 units (SEC Form 4)4 - BIO KEY INTERNATIONAL INC (0001019034) (Issuer)
- INSIDERChief Executive Officer Depasquale Michael W was granted 2,500 shares, increasing direct ownership by 2% to 105,275 units (SEC Form 4)4 - BIO KEY INTERNATIONAL INC (0001019034) (Issuer)
BKYI FAQ
5 questionsWhat does BIO-key International Inc. do?
BIO-key International, Inc., together with its subsidiaries, develops and markets fingerprint identification biometric technology, enterprise-ready identity access management solutions, and software solutions to commercial, government, and education customers in the United States and internationally. The company offers BIO-key PortalGuard and PortalGuard IDaaS solutions, a customer-controlled and neutral-by-design cloud-based identity platform that allows customers to integrate with any cloud or on-premise SaaS application, as well as windows device authentication through IAM platform. Its...Where does BKYI stock trade?
BIO-key International Inc. (BKYI) is listed on NASDAQ.What sector and industry is BKYI in?
BIO-key International Inc. operates in the Technology sector, Computer Software: Prepackaged Software industry.What companies are similar to BKYI?
Notable peers in the same industry include MSFT (Microsoft Corporation), ORCL (Oracle Corporation), SAP (SAP SE), CRM (Salesforce Inc.), CRWD (CrowdStrike Holdings Inc.). Compare BKYI side-by-side with any of them on Quantisnow.How can I track BKYI on Quantisnow?
Quantisnow aggregates BIO-key International Inc.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow BKYI to receive live email and push alerts on every new disclosure.